- Home
- PLSM vs MDCX Comparison
PLSM vs MDCX Comparison
Compare PLSM & MDCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PLSM | MDCX |
|---|---|---|
| Founded | 2014 | 2008 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.7M | 15.9M |
| IPO Year | 2025 | 2025 |
Fundamental Metrics
Financial Performance| Metric | PLSM | MDCX |
|---|---|---|
| Price | $2.22 | $0.17 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $14.50 |
| AVG Volume (30 Days) | 44.8K | ★ 5.3M |
| Earning Date | 03-30-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.26 | $0.14 |
| 52 Week High | $12.97 | $3.05 |
Technical Indicators
Market Signals| Indicator | PLSM | MDCX |
|---|---|---|
| Relative Strength Index (RSI) | 31.47 | 34.28 |
| Support Level | N/A | $0.15 |
| Resistance Level | $2.88 | $0.36 |
| Average True Range (ATR) | 0.24 | 0.02 |
| MACD | 0.02 | 0.00 |
| Stochastic Oscillator | 19.35 | 22.96 |
Price Performance
Historical ComparisonAbout PLSM Pulsenmore Ltd. Ordinary Shares
Pulsenmore Ltd is an emerging medical device company engaged in the research, development, manufacturing, marketing, and sale of non-invasive portable ultrasound solutions for home use. Its products include the Pulsenmore ES and Pulsenmore FC, along with the early-stage Pulsenmore MC, collectively referred to as Pulsenmore Products, enabling remote ultrasound scans in gynecology and other fields such as pulmonary, cardiology, and urology through telemedicine. The Company operates in a single segment focused on developing and commercializing portable ultrasound technologies, with Israel contributing the majority of its revenue.
About MDCX Medicus Pharma Ltd.
Medicus Pharma Ltd is a clinical-stage, life sciences, biotech company focused on investing in and accelerating clinical development programs of novel and potentially disruptive therapeutic assets. The company has one operating segment.